Table 1.
Sex | Patient No. | Percentage |
---|---|---|
Female/Male | 27/28 | 49/51 |
Type of tumor | ||
Lung cancer | 33 | 60 |
Melanoma | 10 | 18 |
Breast cancer | 6 | 10 |
Kidney cancer | 2 | 4 |
Head and neck cancer | 2 | 4 |
Gastrointestinal cancer | 2 | 4 |
Type of oncological treatment | ||
ICIs + chemotherapy | 6 | 11 |
ICIs | 32 | 58 |
Chemotherapy | 17 | 31 |
Type of ICI | ||
Pembrolizumab | 20 | 36 |
Nivolumab | 12 | 22 |
Atezolizumab | 4 | 7 |
Durvalumab | 2 | 4 |
Legend: ICI: immune-checkpoint inhibitor.